Soluble beta-glucan (SBG)

DRUG2 trials

Sponsors

Biotec Pharmacon ASA

Conditions

Chronic Diabetic Foot UlcersNon-Hodgkin's Lymphoma

Phase 1

Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's Lymphoma

CompletedNCT00533728

Biotec Pharmacon ASANon-Hodgkin's Lymphoma

Start: 2007-09-30End: 2009-03-31Target: 12Updated: 2009-03-04

Phase 3

Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers

CompletedNCT00632008

Biotec Pharmacon ASAChronic Diabetic Foot Ulcers

Start: 2007-03-31End: 2009-10-31Updated: 2010-01-26